Experts call for more clinical trials on alcohol use, liver disease

More clinical research is needed to investigate how reducing alcohol consumption in patients with alcohol-related liver disease (ALD) may slow disease progression and improve outcomes, according to an international task force of experts from more than two dozen institutions including UT Southwestern Medical Center. In a consensus statement published in Nature Reviews Gastroenterology & Hepatology, the group, commissioned by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), issued a set of 28 recommendations to guide the design of future clinical trials addressing alcohol use disorder (AUD) and ALD. The Read More

Related posts:

  1. Further transparency needed in cancer clinical trials
  2. Whose health matters? The diversity deficit in clinical trials
  3. New study finds systematic biases at play in clinical trials
  4. A call for renaming clinical research partnerships
  5. Firearm-violence public health crisis ‘a wake-up call,’ say experts
  6. A novel liver patch could help treat and prevent liver disease
  7. New survey finds cancer drug shortage management remains a moving target, impacting clinical trials
  8. Study uncovers multiple molecular subgroups in liver cancer with most aggressive driving clinical outcomes

Leave a Reply

Your email address will not be published. Required fields are marked *